PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB COMPARED TO CELECOXIB FOR THE TREATMENT OF OSTEOARTHRITIS IN CANADA
May 1, 2007, 00:00 AM
10.1016/S1098-3015(10)68895-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)68895-X/fulltext
Section Title :
Section Order :
69
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68895-X&doi=10.1016/S1098-3015(10)68895-X